Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718 ) - R3 - Effective March 12, 2024

Date Posted: March 21, 2024

This coverage article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: March 12, 2024

Summary of Article Changes:

Under CPT/HCPCS Codes Group 1: Codes added 0005U. Under CPT/HCPCS Codes Group 2: Codes added 0005U. This revision is due to new covered assay that has successfully completed a TA and is effective 12/27/2023.

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

Last Updated Apr 08 , 2024